The cheapest GLP-1 with insurance is roughly $25/month on Wegovy, Zepbound, Ozempic, Mounjaro, or Foundayo when your commercial plan covers the drug and you stack the manufacturer savings card. Only 43% of commercially insured users hit that scenario. When insurance won't cover a weight-loss GLP-1, PlexusDx cash-pay protocols start at $129/mo flat - cheaper than every branded self-pay route.

MEDVi’s ongoing compounded semaglutide rate is $299/month, with multi-month prepaid plans also offered. We reconcile MEDVi’s pricing against PlexusDx Semaglutide Injection ($189/mo) and Semaglutide Oral ($289/mo) on a 12-month total-cost basis — with the genetic baseline MEDVi doesn’t offer.

Is GLP-1 HRA, FSA, or HSA eligible? Often yes when prescribed for a diagnosed condition, but the rules vary by plan. Here is the framework, the documentation you need, and where PlexusDx Weight Management Protocols (from $129/mo, all 50 states, no membership) fit when your account does not cover GLP-1s for weight loss.

Florida residents can legally start GLP-1 telehealth in days under Statute §456.47. We compare MEDVi, Ro, Walgreens, and the PlexusDx Microdose GLP-1 Protocol from $129/mo — with a genetic baseline option no other Florida provider offers.

A GLP-1 program under $300/month is real in 2026 if you pick a structure that doesn't reset in month two. Four PlexusDx protocols stay under the cap at every published dose tier: Microdose GLP-1 Protocol at $129/mo flat, Semaglutide Injection at $189/mo (or $149/mo on the 6-month plan), Tirzepatide Injection at $289/mo (or $249/mo on the 6-month plan), and GLP-Squared at $289/mo (or $249/mo on the 3-month plan) — all cash-pay, all-inclusive, no membership.

The honest list of GLP-1 options under $200/mo in April 2026 is much shorter than the ads suggest. PlexusDx Microdose GLP-1 Protocol at $129/mo flat is the lowest under-$200 option in this comparison, with PlexusDx Semaglutide Injection at $189/mo month-to-month (or $149/mo on the 6-month plan) as the lowest weekly compounded semaglutide path. FDA-approved Foundayo and the Wegovy pill start at $149/mo at lower doses but escalate with dose; most other “$199 GLP-1” ads are first-month-only promos that jump to $249–$349 on refill.

The full 2026 GLP-1 cost map: Wegovy, Ozempic, Zepbound, and Mounjaro at branded list price; Lilly Direct and NovoCare manufacturer self-pay programs ($149–$499/mo); cash-pay compounded telehealth alternatives. PlexusDx Weight Management Protocols span $129/mo to $349/mo with all-inclusive pricing, no membership, all 50 states.

Foundayo's $149 headline is a one-month starter price — the real cash-pay year runs $3,338–$3,738 once you escalate. Compare PlexusDx Microdose GLP-1 ($129/mo flat), Semaglutide Oral ($289/mo), and Tirzepatide Oral ($349/mo) on annualized cost.

Foundayo costs $25/month with covered commercial insurance, $50/month on the Medicare GLP-1 Bridge, or $149-$289/mo self-pay through LillyDirect. Most commercial plans don't cover GLP-1s for weight loss in 2026. Compare cash-pay PlexusDx Weight Management Protocols — Microdose at $129/mo flat, Semaglutide Injection $189/mo, Tirzepatide Injection $289/mo — with no membership fee.

Eden vs Ro vs PlexusDx for cash-pay GLP-1: Eden's $298 advertised semaglutide runs $198/mo all-in with its required membership (verified July 2026); Ro pairs a $149/mo membership with branded medication billed on top; PlexusDx runs $129/mo to $349/mo month to month with an optional genetic baseline.

MEDVi’s compounded plans bundle medication and platform into one price (no separate membership fee); branded Wegovy/Zepbound paths add a separate membership. We reconcile MEDVi’s fee structure, its recurring monthly billing, and where PlexusDx Weight Management Protocols sit at $129/mo to $349/mo with no membership fee on any tier.

Medicare Part D is statutorily prohibited from covering GLP-1s prescribed solely for weight loss, and manufacturer copay cards are off-limits to Medicare beneficiaries. This guide explains the Medicare GLP-1 Bridge launching July 2026, Part D backdoors for diabetes, CVD, and OSA, and the cash-pay options that work today — including PlexusDx Microdose GLP-1 Protocol at $129/mo flat and Semaglutide Injection at $189/mo month-to-month, or from $149/mo on the 6-month plan.

How PlexusDx Weight Management Protocols compare to the major cash-pay GLP-1 programs in 2026 — Mochi, Eden, MEDVi, Ro, GoodRx Care Direct, NovoCare, and LillyDirect — on price, medication source, membership fees, and total annualized cost.

With insurance, what you pay for Mounjaro turns on your formulary, the indication on your prescription, and prior authorization. This guide explains how coverage becomes a copay, how a manufacturer savings card stacks on top, what Medicare's separate rules mean, and what your options are if the plan says no.

Advertised Mounjaro discounts can mislead if you do not know the list price and coverage rules they sit on. This overview explains the published price, the two discount routes, how insurance shapes the outcome, and where compounded protocols fit, so the numbers you see make sense.

Coupons for Mounjaro come in two flavors that people often confuse. This guide separates manufacturer savings cards from pharmacy discount platforms, explains who qualifies for each, and shows how insurance status and the compounding window shape the final counter price.

Wegovy's monthly cost is one of the most-searched GLP-1 questions. This guide explains what drives it — list price, insurance and prior authorization, manufacturer savings cards, third-party coupons, and compounded alternatives — plus the genetic context that sits upstream of any protocol decision.

A coupon rarely tells the whole Ozempic story. This reality check explains how manufacturer savings cards differ from pharmacy discount-platform coupons, how your insurance status flips which one actually helps, why quoted prices keep shifting, and how the compounded semaglutide pathway sits apart from both.

The Wegovy cash price starts from a published list figure and bends around insurance, indication, and savings tools. This page breaks down the sticker cost, what moves it at the counter, and the separately priced compounded pathway, all as of April 2026.

With insurance, Ozempic's price comes down to your plan's rules rather than the list figure. This page explains how formulary placement, prior authorization, and the FDA indication shape your copay, how savings cards stack on top, and the genetic context beneath it.

GoodRx quotes for Mounjaro rarely match list or insurance figures. This guide untangles what actually drives the cost as of April 2026: the published list price, insurance and prior authorization, savings cards and discount platforms, the compounding landscape, and the genetics underneath.

GoodRx and similar platforms are one piece of the tirzepatide pricing puzzle, not the whole answer. This guide explains how discount cards compare to list price, insurance, and manufacturer savings cards, and where compounded pathways and genetics fit the decision.

Semaglutide is the molecule behind several brands, so its price shows up as a range rather than one number. This guide explains the roughly $968 to $1,029 April 2026 list span, the coverage math, and how compounded and PlexusDx protocol pricing compares.

Tirzepatide cost depends on list price, insurance, the prescription's indication, and savings-card eligibility. This molecule-level guide covers the roughly $1,069 monthly list price, the variables that shift it at the counter, and the genetic pathways beneath any GLP-1 decision you weigh.

The Mounjaro injection price online can look wildly different from one source to the next. This page explains what actually drives the number: the published list price, insurance and prior-authorization rules, manufacturer savings cards, and where compounded alternatives fit into the cost picture.

How far Mounjaro’s real price can drop from its roughly $1,069 list price, lever by lever: insurance coverage and prior authorization, the manufacturer savings card, Medicare limits, the 2024–2025 compounding shift, and the out-of-pocket scenarios eligible patients actually see.

Semaglutide is the molecule inside several branded products, so its cost varies by form, insurance, and pharmacy. This guide clarifies the April 2026 list price range, coverage and savings factors, and why understanding your metabolic genetics comes before any protocol decision.

Without coverage, Mounjaro's cash price starts near the roughly $1,069 list figure. This guide covers the coupons that still work when you are uninsured, why the manufacturer card usually will not apply, how the compounded-pharmacy lane compares, and a realistic cash scenario for anyone paying out of pocket.

Quoted Mounjaro prices rarely match reality. This page breaks down what drives out-of-pocket cost — the roughly $1,069 list price, insurance and prior authorization, manufacturer savings cards, compounded options after the 2024–2025 shortages, and typical scenarios — plus the genetics behind any GLP-1 decision.

Tirzepatide coupons come in two flavors, manufacturer savings cards and independent discount platforms, each with different rules and eligibility. This guide explains how both work, how coverage and list price frame them, what fine print to read, and why genetics belong in the decision first.